Medical News

RSS

GE Healthcare uses Eurotech TurboXb computer on module in EView ventilator data capture device

Eurotech, a leading supplier of embedded technologies, products, and systems and a strategic supplier to GE Healthcare, today announces the Eurotech TurboXb computer on module has been deployed in GE Healthcare's EView ventilator data capture device, in accordance with the contract announced on Nov 12, 2009.

31 Aug 2010

ESC issues revised practice guidelines for management of AF

The European Society of Cardiology today issued revised practice guidelines for the management of atrial fibrillation, including guidance on the role of a novel oral treatment, dabigatran etexilate, for the prevention of stroke and systemic embolism in patients with atrial fibrillation.

31 Aug 2010

Seredor acquires South Florida-based operator of sleep diagnostic centers

Continucare Corporation announced today that its wholly owned subsidiary Seredor Corporation has expanded its sleep center operations through the acquisition of a South Florida-based operator of sleep diagnostic centers. The acquired business currently operates two independent diagnostic testing facilities.

31 Aug 2010

Study shows DERMACYTE Oxygen Concentrate improves skin appearance

Oxygen Biotherapeutics, Inc. today announced that results from an 8-week cosmetic study showed that the topical application of DERMACYTE Oxygen Concentrate, an oxygen-rich skin care lotion, appears to improve the appearance of fine lines and the perception of skin appearance.

31 Aug 2010

Study on conflict between capacity to pay and need for health care

Cardiovascular disease (CVD) in all its forms is the biggest cause of death across Europe. Although there is little doubt that better focus on prevention can lessen its impact, we are left with a series of fundamental questions to what extent can the impact be reduced, and at what cost. And are the health benefits of prevention worth the investment. The EUROASPIRE III health economics study aims to find out.

31 Aug 2010

Halozyme identifies strategy to reintroduce HYLENEX

Halozyme Therapeutics, Inc. today announced the completion of its root cause investigation regarding HYLENEX manufacturing and has identified a corrective action plan and regulatory strategy to reintroduce HYLENEX to the market. Halozyme and Baxter are finalizing the materials for a meeting with the U.S. Food and Drug Administration to seek concurrence with the reintroduction strategy.

31 Aug 2010

Pathology experts to evaluate medical, surgical breast cancer treatment at World Senologyc Congress

Spain will held the 16th World Senologyc Congress between the 20th and 22nd of October. This meeting will allow doctors to evaluate the progress achieved in medical and surgical breast cancer treatment and its future challenges. The best time to rebuilding breasts, how to preserve patients' fertility, the use of nodes self-transplant to treat lymphedema, the develop of new molecular targets and the use of stem cells will be some of the key issues to be treated during the congress.

31 Aug 2010

Naurex announces GLYX-13 molecule recognized in “Top 10 to Watch" list for depression treatment

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that its clinical stage candidate for the treatment of depression, GLYX-13, and its second-generation NRX-1050 series have been selected for inclusion on Windhover's list of the "Top 10 Most Interesting Neuroscience Projects to Watch."

31 Aug 2010

CPA and Nightingale launch interactive Personal Health Record portal

Canadian Patient Access Inc. and Nightingale Informatix Corporation today announce the launch of myPatientAccess.ca, Canada's first interactive patient portal to be fully integrated with an electronic medical records (EMR) system. A breakthrough offering in consumer healthcare, Canadian patients will, for the first time, have full, web-based, real-time access to their Personal Health Record (PHR), with information that has been validated by their physician.

31 Aug 2010

LocateADoc.com launches new Vein Treatment specialty procedures

Due to Americans living increasingly sedentary lifestyles, coupled with being overweight, which is a leading cause of varicose veins, more and more adults are seeking both surgical and non-surgical treatments to remove their varicose veins.

31 Aug 2010

TearLab and AMO Canada enter cooperative marketing agreement

TearLab Corporation today announced that it has entered into a cooperative marketing agreement with Abbott Medical Optics Inc.'s subsidiary, AMO Canada Company. Under the agreement, AMO Canada's sales force will directly sell the TearLab™ Osmolarity System in Canada while TearLab will help promote AMO Canada's products for the relief of dry eye symptoms, including Blink® Moisturizing Eye Drops. Financial terms were not disclosed.

31 Aug 2010

CIGNA completes acquisition of Vanbreda International

Global health service company CIGNA has acquired Vanbreda International, based in Antwerp, Belgium, giving CIGNA unmatched global reach in expatriate benefits and further accelerating CIGNA's global growth strategy.

31 Aug 2010

UCI receives grant to promote patient-centered care

UC Irvine's Department of Anesthesiology & Perioperative Care has been awarded a Picker Institute/Gold Foundation Challenge Grant to change how anesthesiologists are trained, emphasizing the skills necessary to treat patients with compassion and empathy under difficult conditions.

31 Aug 2010

First Edition: August 31, 2010

"These days, you may leave your dentist's office with more than a toothbrush and dental floss in your bag. Thousands of dentists are offering patients health-care credit cards to cover the work that needs to be done, with seemingly hard-to-resist repayment terms. If you need care and don't have insurance to cover it or cash in hand, it's tempting to sign up" (Kaiser Health News).

31 Aug 2010

Recommendations for revascularisation in coronary artery disease patients

There have been several studies into the impact of completeness of revascularisation in recent years, yet few clear recommendations are available on the likely clinical outcomes. This topic is not formally addressed in either the European Society of Cardiology guidelines or those jointly issued by the American Heart Association and American College of Cardiology.

31 Aug 2010

Findings suggest sustainable school-base prevention program for youth at risk for substance abuse

The coming weeks mark the return to school for many of our youngest citizens. Sadly the satisfaction of making new friends and obtaining good test scores may be overshadowed by the prospect of substance abuse for some school-aged adolescents. The previous decade has witnessed a two-fold increase in both alcohol consumption and intoxication by adolescents age 12 to 17.

31 Aug 2010

DANPACE trial shows dual chamber pacing decreases atrial fibrillation in sick sinus syndrome

DANPACE, a Danish multicentre randomised trial comparing single lead atrial and dual chamber pacing in patients with sick sinus syndrome, concludes that dual chamber pacing, which was associated with lower rates of atrial fibrillation and re-operation, "should be the preferred pacing mode".

31 Aug 2010

Standard dose of UFH optimal for treatment of PCI patients on fondaparinux: Study

A landmark international study, coordinated by McMaster University, has found that lower doses of a blood thinner called unfractionated heparin (UFH) during angioplasty did not reduce bleeding or vascular complications compared to standard dose UFH in patients initially treated with a blood thinner, fondaparinux.

31 Aug 2010

Scientists find effective training regimens to determine exercise intensity

For competitive bicyclists with goals - whether competing in the Tour de France or aiming for the podium at a local race - faster cycling comes from training regimens based on various zones of exercise intensity. New research from exercise scientists at the University of New Hampshire has found that effective training regimens, which generally are created after expensive, time-consuming laboratory tests, can be developed from a relatively simple, do-it-yourself test.

31 Aug 2010